{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T13:30:04Z","timestamp":1780752604471,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T00:00:00Z","timestamp":1604880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"internal funding source (departmental funding) in Xingtai People\u2019s Hospital"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cell Biochem"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1007\/s11010-020-03968-4","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T09:08:56Z","timestamp":1604912936000},"page":"1025-1036","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["MiR-3613-3p inhibits hypertrophic scar formation by down-regulating arginine and glutamate-rich 1"],"prefix":"10.1007","volume":"476","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7180-4725","authenticated-orcid":false,"given":"Lisha","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiang","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,9]]},"reference":[{"key":"3968_CR1","doi-asserted-by":"publisher","first-page":"565","DOI":"10.6061\/clinics\/2014(08)11","volume":"69","author":"FB Rabello","year":"2014","unstructured":"Rabello FB, Souza CD, Farina Junior JA (2014) Update on hypertrophic scar treatment Clinics (Sao Paulo) 69:565\u2013573","journal-title":"Update on hypertrophic scar treatment Clinics (Sao Paulo)"},{"key":"3968_CR2","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1097\/GOX.0b013e31829c4597","volume":"1","author":"C Huang","year":"2013","unstructured":"Huang C, Murphy GF, Akaishi S, Ogawa R (2013) Keloids and hypertrophic scars: update and future directions. Plast Reconstr Surg Glob Open 1:e25. https:\/\/doi.org\/10.1097\/GOX.0b013e31829c4597","journal-title":"Plast Reconstr Surg Glob Open"},{"key":"3968_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.2119\/molmed.2009.00153","volume":"17","author":"GG Gauglitz","year":"2011","unstructured":"Gauglitz GG, Korting HC, Pavicic T, Ruzicka T, Jeschke MG (2011) Hypertrophic scarring and keloids: pathomechanisms and current and emerging treatment strategies. Mol Med 17:113\u2013125. https:\/\/doi.org\/10.2119\/molmed.2009.00153","journal-title":"Mol Med"},{"key":"3968_CR4","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1111\/1523-1747.ep12606979","volume":"104","author":"K Zhang","year":"1995","unstructured":"Zhang K, Garner W, Cohen L, Rodriguez J, Phan S (1995) Increased types I and III collagen and transforming growth factor-beta 1 mRNA and protein in hypertrophic burn scar. J Invest Dermatol 104:750\u2013754. https:\/\/doi.org\/10.1111\/1523-1747.ep12606979","journal-title":"J Invest Dermatol"},{"key":"3968_CR5","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/01.mop.0000236389.41462.ef","volume":"18","author":"AE Slemp","year":"2006","unstructured":"Slemp AE, Kirschner RE (2006) Keloids and scars: a review of keloids and scars, their pathogenesis, risk factors, and management. Curr Opin Pediatr 18:396\u2013402. https:\/\/doi.org\/10.1097\/01.mop.0000236389.41462.ef","journal-title":"Curr Opin Pediatr"},{"key":"3968_CR6","doi-asserted-by":"publisher","first-page":"265sr6","DOI":"10.1126\/scitranslmed.3009337","volume":"6","author":"SA Eming","year":"2014","unstructured":"Eming SA, Martin P, Tomic-Canic M (2014) Wound repair and regeneration: mechanisms, signaling, and translation. Sci Transl Med 6:265sr6. https:\/\/doi.org\/10.1126\/scitranslmed.3009337","journal-title":"Sci Transl Med"},{"key":"3968_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1365-2133.2009.09258.x","volume":"161","author":"JJ Brown","year":"2009","unstructured":"Brown JJ, Bayat A (2009) Genetic susceptibility to raised dermal scarring. Br J Dermatol 161:8\u201318. https:\/\/doi.org\/10.1111\/j.1365-2133.2009.09258.x","journal-title":"Br J Dermatol"},{"key":"3968_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030711","author":"HJ Lee","year":"2018","unstructured":"Lee HJ, Jang YJ (2018) Recent understandings of biology, prophylaxis and treatment strategies for hypertrophic scars and keloids. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19030711","journal-title":"Int J Mol Sci"},{"issue":"301\u201310","key":"3968_CR9","doi-asserted-by":"publisher","first-page":"vi","DOI":"10.1016\/j.pmr.2011.02.002","volume":"22","author":"V Gabriel","year":"2011","unstructured":"Gabriel V (2011) Hypertrophic scar. Phys Med Rehabil Clin N Am 22(301\u201310):vi. https:\/\/doi.org\/10.1016\/j.pmr.2011.02.002","journal-title":"Phys Med Rehabil Clin N Am"},{"key":"3968_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.cps.2009.05.014","volume":"36","author":"A Ladak","year":"2009","unstructured":"Ladak A, Tredget EE (2009) Pathophysiology and management of the burn scar. Clin Plast Surg 36:661\u2013674. https:\/\/doi.org\/10.1016\/j.cps.2009.05.014","journal-title":"Clin Plast Surg"},{"key":"3968_CR11","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1016\/S0140-6736(16)31406-4","volume":"388","author":"CC Finnerty","year":"2016","unstructured":"Finnerty CC, Jeschke MG, Branski LK, Barret JP, Dziewulski P, Herndon DN (2016) Hypertrophic scarring: the greatest unmet challenge after burn injury. Lancet 388:1427\u20131436. https:\/\/doi.org\/10.1016\/S0140-6736(16)31406-4","journal-title":"Lancet"},{"key":"3968_CR12","doi-asserted-by":"publisher","first-page":"e234","DOI":"10.1371\/journal.pmed.0040234","volume":"4","author":"S Aarabi","year":"2007","unstructured":"Aarabi S, Longaker MT, Gurtner GC (2007) Hypertrophic scar formation following burns and trauma: new approaches to treatment. PLoS Med 4:e234. https:\/\/doi.org\/10.1371\/journal.pmed.0040234","journal-title":"PLoS Med"},{"key":"3968_CR13","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.fsc.2014.04.010","volume":"22","author":"MO Visscher","year":"2014","unstructured":"Visscher MO, Bailey JK, Hom DB (2014) Scar treatment variations by skin type. Facial Plast Surg Clin North Am 22:453\u2013462. https:\/\/doi.org\/10.1016\/j.fsc.2014.04.010","journal-title":"Facial Plast Surg Clin North Am"},{"key":"3968_CR14","doi-asserted-by":"publisher","first-page":"402","DOI":"10.3389\/fendo.2018.00402","volume":"9","author":"J O'Brien","year":"2018","unstructured":"O\u2019Brien J, Hayder H, Zayed Y, Peng C (2018) Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne) 9:402. https:\/\/doi.org\/10.3389\/fendo.2018.00402","journal-title":"Front Endocrinol (Lausanne)"},{"key":"3968_CR15","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/s41580-018-0045-7","volume":"20","author":"LFR Gebert","year":"2019","unstructured":"Gebert LFR, MacRae IJ (2019) Regulation of microRNA function in animals. Nat Rev Mol Cell Biol 20:21\u201337. https:\/\/doi.org\/10.1038\/s41580-018-0045-7","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3968_CR16","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1038\/nrm3838","volume":"15","author":"M Ha","year":"2014","unstructured":"Ha M, Kim VN (2014) Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol 15:509\u2013524. https:\/\/doi.org\/10.1038\/nrm3838","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3968_CR17","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1007\/s40291-017-0294-8","volume":"21","author":"Y Li","year":"2017","unstructured":"Li Y, Zhang J, Lei Y, Lyu L, Zuo R, Chen T (2017) MicroRNA-21 in skin fibrosis: potential for diagnosis and treatment. Mol Diagn Ther 21:633\u2013642. https:\/\/doi.org\/10.1007\/s40291-017-0294-8","journal-title":"Mol Diagn Ther"},{"key":"3968_CR18","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1002\/jcb.25873","volume":"118","author":"L Chen","year":"2017","unstructured":"Chen L, Li J, Li Q, Yan H, Zhou B, Gao Y, Li J (2017) Non-coding RNAs: the new insight on hypertrophic scar. J Cell Biochem 118:1965\u20131968. https:\/\/doi.org\/10.1002\/jcb.25873","journal-title":"J Cell Biochem"},{"key":"3968_CR19","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00018-015-1853-y","volume":"72","author":"J Wang","year":"2015","unstructured":"Wang J, Zhang Y, Zhang N, Wang C, Herrler T, Li Q (2015) An updated review of mechanotransduction in skin disorders: transcriptional regulators, ion channels, and microRNAs. Cell Mol Life Sci 72:2091\u20132106. https:\/\/doi.org\/10.1007\/s00018-015-1853-y","journal-title":"Cell Mol Life Sci"},{"key":"3968_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.yexcr.2017.09.009","volume":"361","author":"X Wang","year":"2017","unstructured":"Wang X, Zhang Y, Jiang BH, Zhang Q, Zhou RP, Zhang L, Wang C (2017) Study on the role of Hsa-miR-31-5p in hypertrophic scar formation and the mechanism. Exp Cell Res 361:201\u2013209. https:\/\/doi.org\/10.1016\/j.yexcr.2017.09.009","journal-title":"Exp Cell Res"},{"key":"3968_CR21","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1165\/rcmb.2010-0323OC","volume":"45","author":"L Cushing","year":"2011","unstructured":"Cushing L, Kuang PP, Qian J, Shao F, Wu J, Little F, Thannickal VJ, Cardoso WV, Lu J (2011) miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 45:287\u2013294. https:\/\/doi.org\/10.1165\/rcmb.2010-0323OC","journal-title":"Am J Respir Cell Mol Biol"},{"key":"3968_CR22","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1038\/mt.2012.35","volume":"20","author":"L Wang","year":"2012","unstructured":"Wang L, Zhou L, Jiang P, Lu L, Chen X, Lan H, Guttridge DC, Sun H, Wang H (2012) Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol Ther 20:1222\u20131233. https:\/\/doi.org\/10.1038\/mt.2012.35","journal-title":"Mol Ther"},{"key":"3968_CR23","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1038\/mt.2014.25","volume":"22","author":"Y Zhang","year":"2014","unstructured":"Zhang Y, Huang XR, Wei LH, Chung AC, Yu CM, Lan HY (2014) miR-29b as a therapeutic agent for angiotensin II-induced cardiac fibrosis by targeting TGF-beta\/Smad3 signaling. Mol Ther 22:974\u2013985. https:\/\/doi.org\/10.1038\/mt.2014.25","journal-title":"Mol Ther"},{"key":"3968_CR24","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1159\/000493236","volume":"49","author":"Q Zhang","year":"2018","unstructured":"Zhang Q, Guo B, Hui Q, Chang P, Tao K (2018) miR-137 inhibits proliferation and metastasis of hypertrophic scar fibroblasts via targeting pleiotrophin. Cell Physiol Biochem 49:985\u2013995. https:\/\/doi.org\/10.1159\/000493236","journal-title":"Cell Physiol Biochem"},{"key":"3968_CR25","doi-asserted-by":"publisher","first-page":"1451","DOI":"10.1016\/j.bbadis.2015.04.013","volume":"1852","author":"S Zanotti","year":"2015","unstructured":"Zanotti S, Gibertini S, Curcio M, Savadori P, Pasanisi B, Morandi L, Cornelio F, Mantegazza R, Mora M (2015) Opposing roles of miR-21 and miR-29 in the progression of fibrosis in Duchenne muscular dystrophy. Biochim Biophys Acta 1852:1451\u20131464. https:\/\/doi.org\/10.1016\/j.bbadis.2015.04.013","journal-title":"Biochim Biophys Acta"},{"key":"3968_CR26","doi-asserted-by":"publisher","first-page":"e58014","DOI":"10.1371\/journal.pone.0058014","volume":"8","author":"F Glowacki","year":"2013","unstructured":"Glowacki F, Savary G, Gnemmi V, Buob D, Van der Hauwaert C, Lo-Guidice JM, Bouye S, Hazzan M, Pottier N, Perrais M, Aubert S, Cauffiez C (2013) Increased circulating miR-21 levels are associated with kidney fibrosis. PLoS ONE 8:e58014. https:\/\/doi.org\/10.1371\/journal.pone.0058014","journal-title":"PLoS ONE"},{"key":"3968_CR27","doi-asserted-by":"publisher","first-page":"49","DOI":"10.3389\/fphys.2012.00049","volume":"3","author":"A Noetel","year":"2012","unstructured":"Noetel A, Kwiecinski M, Elfimova N, Huang J, Odenthal M (2012) microRNA are central players in anti- and profibrotic gene regulation during liver fibrosis. Front Physiol 3:49. https:\/\/doi.org\/10.3389\/fphys.2012.00049","journal-title":"Front Physiol"},{"key":"3968_CR28","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.1016\/j.ajpath.2012.08.022","volume":"181","author":"T Wang","year":"2012","unstructured":"Wang T, Feng Y, Sun H, Zhang L, Hao L, Shi C, Wang J, Li R, Ran X, Su Y, Zou Z (2012) miR-21 regulates skin wound healing by targeting multiple aspects of the healing process. Am J Pathol 181:1911\u20131920. https:\/\/doi.org\/10.1016\/j.ajpath.2012.08.022","journal-title":"Am J Pathol"},{"key":"3968_CR29","doi-asserted-by":"publisher","first-page":"e97114","DOI":"10.1371\/journal.pone.0097114","volume":"9","author":"HY Zhu","year":"2014","unstructured":"Zhu HY, Li C, Bai WD, Su LL, Liu JQ, Li Y, Shi JH, Cai WX, Bai XZ, Jia YH, Zhao B, Wu X, Li J, Hu DH (2014) MicroRNA-21 regulates hTERT via PTEN in hypertrophic scar fibroblasts. PLoS ONE 9:e97114. https:\/\/doi.org\/10.1371\/journal.pone.0097114","journal-title":"PLoS ONE"},{"key":"3968_CR30","doi-asserted-by":"publisher","first-page":"685","DOI":"10.7150\/ijbs.7.685","volume":"7","author":"X Yang","year":"2011","unstructured":"Yang X, Wang J, Guo SL, Fan KJ, Li J, Wang YL, Teng Y, Yang X (2011) miR-21 promotes keratinocyte migration and re-epithelialization during wound healing. Int J Biol Sci 7:685\u2013690. https:\/\/doi.org\/10.7150\/ijbs.7.685","journal-title":"Int J Biol Sci"},{"key":"3968_CR31","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1007\/s00266-011-9773-1","volume":"36","author":"Y Liu","year":"2012","unstructured":"Liu Y, Yang D, Xiao Z, Zhang M (2012) miRNA expression profiles in keloid tissue and corresponding normal skin tissue. Aesthetic Plast Surg 36:193\u2013201. https:\/\/doi.org\/10.1007\/s00266-011-9773-1","journal-title":"Aesthetic Plast Surg"},{"key":"3968_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1111\/j.1742-481X.2009.00638.x","volume":"6","author":"GV Oliveira","year":"2009","unstructured":"Oliveira GV, Hawkins HK, Chinkes D, Burke A, Tavares AL, Ramos-e-Silva M, Albrecht TB, Kitten GT, Herndon DN (2009) Hypertrophic versus non hypertrophic scars compared by immunohistochemistry and laser confocal microscopy: type I and III collagens. Int Wound J 6:445\u2013452. https:\/\/doi.org\/10.1111\/j.1742-481X.2009.00638.x","journal-title":"Int Wound J"},{"key":"3968_CR33","doi-asserted-by":"publisher","first-page":"ZC14","DOI":"10.7860\/JCDR\/2014\/7820.4231","volume":"8","author":"KB Rao","year":"2014","unstructured":"Rao KB, Malathi N, Narashiman S, Rajan ST (2014) Evaluation of myofibroblasts by expression of alpha smooth muscle actin: a marker in fibrosis, dysplasia and carcinoma. J Clin Diagn Res 8:ZC14-17. https:\/\/doi.org\/10.7860\/JCDR\/2014\/7820.4231","journal-title":"J Clin Diagn Res"},{"key":"3968_CR34","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.bbadis.2016.11.006","volume":"1863","author":"AV Shinde","year":"2017","unstructured":"Shinde AV, Humeres C, Frangogiannis NG (2017) The role of alpha-smooth muscle actin in fibroblast-mediated matrix contraction and remodeling. Biochim Biophys Acta Mol Basis Dis 1863:298\u2013309. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.006","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"3968_CR35","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/1523-1747.ep12874489","volume":"94","author":"M Arakawa","year":"1990","unstructured":"Arakawa M, Hatamochi A, Takeda K, Ueki H (1990) Increased collagen synthesis accompanying elevated m-RNA levels in cultured Werner\u2019s syndrome fibroblasts. J Invest Dermatol 94:187\u2013190","journal-title":"J Invest Dermatol"},{"key":"3968_CR36","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/s11010-016-2699-9","volume":"416","author":"S Mu","year":"2016","unstructured":"Mu S, Kang B, Zeng W, Sun Y, Yang F (2016) MicroRNA-143-3p inhibits hyperplastic scar formation by targeting connective tissue growth factor CTGF\/CCN2 via the Akt\/mTOR pathway. Mol Cell Biochem 416:99\u2013108. https:\/\/doi.org\/10.1007\/s11010-016-2699-9","journal-title":"Mol Cell Biochem"},{"key":"3968_CR37","doi-asserted-by":"publisher","first-page":"93014","DOI":"10.18632\/oncotarget.21745","volume":"8","author":"D Zhang","year":"2017","unstructured":"Zhang D, Liu E, Kang J, Yang X, Liu H (2017) MiR-3613-3p affects cell proliferation and cell cycle in hepatocellular carcinoma. Oncotarget 8:93014\u201393028. https:\/\/doi.org\/10.18632\/oncotarget.21745","journal-title":"Oncotarget"},{"key":"3968_CR38","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.2147\/OTT.S169233","volume":"11","author":"W Yan","year":"2018","unstructured":"Yan W, Yang W, Liu Z, Wu G (2018) Characterization of microRNA expression in primary human colon adenocarcinoma cells (SW480) and their lymph node metastatic derivatives (SW620). Onco Targets Ther 11:4701\u20134709. https:\/\/doi.org\/10.2147\/OTT.S169233","journal-title":"Onco Targets Ther"},{"key":"3968_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.3233\/CBM-170496","volume":"22","author":"A Fricke","year":"2018","unstructured":"Fricke A, Cimniak AFV, Ullrich PV, Becherer C, Bickert C, Pfeifer D, Heinz J, Stark GB, Bannasch H, Braig D, Eisenhardt SU (2018) Whole blood miRNA expression analysis reveals miR-3613-3p as a potential biomarker for dedifferentiated liposarcoma. Cancer Biomark 22:199\u2013207. https:\/\/doi.org\/10.3233\/CBM-170496","journal-title":"Cancer Biomark"},{"key":"3968_CR40","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1002\/hep.29690","volume":"67","author":"AK Singh","year":"2018","unstructured":"Singh AK, Rooge SB, Varshney A, Vasudevan M, Bhardwaj A, Venugopal SK, Trehanpati N, Kumar M, Geffers R, Kumar V, Sarin SK (2018) Global microRNA expression profiling in the liver biopsies of hepatitis B virus-infected patients suggests specific microRNA signatures for viral persistence and hepatocellular injury. Hepatology 67:1695\u20131709. https:\/\/doi.org\/10.1002\/hep.29690","journal-title":"Hepatology"},{"key":"3968_CR41","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1177\/1753425919826342","volume":"25","author":"H Jiao","year":"2019","unstructured":"Jiao H, Zheng Z, Shuai X, Wu L, Chen J, Luo Y, Zhao Y, Wang H, Huang Q (2019) MicroRNA expression profiles from HEK293 cells expressing H5N1 avian influenza virus non-structural protein 1. Innate Immun 25:110\u2013117. https:\/\/doi.org\/10.1177\/1753425919826342","journal-title":"Innate Immun"},{"key":"3968_CR42","doi-asserted-by":"publisher","first-page":"e0139233","DOI":"10.1371\/journal.pone.0139233","volume":"10","author":"G Lugli","year":"2015","unstructured":"Lugli G, Cohen AM, Bennett DA, Shah RC, Fields CJ, Hernandez AG, Smalheiser NR (2015) Plasma exosomal miRNAs in persons with and without Alzheimer disease: altered expression and prospects for biomarkers. PLoS ONE 10:e0139233. https:\/\/doi.org\/10.1371\/journal.pone.0139233","journal-title":"PLoS ONE"},{"key":"3968_CR43","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1002\/jcb.25354","volume":"117","author":"E Boratyn","year":"2016","unstructured":"Boratyn E, Nowak I, Horwacik I, Durbas M, Mistarz A, Kukla M, Kaczowka P, Lastowska M, Jura J, Rokita H (2016) Monocyte chemoattractant protein-induced protein 1 overexpression modulates transcriptome, including microRNA, in human neuroblastoma cells. J Cell Biochem 117:694\u2013707. https:\/\/doi.org\/10.1002\/jcb.25354","journal-title":"J Cell Biochem"},{"key":"3968_CR44","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2019.04.010","author":"KS Patil","year":"2019","unstructured":"Patil KS, Basak I, Dalen I, Hoedt E, Lange J, Lunde KA, Liu Y, Tysnes OB, Forsgren L, Aarsland D, Neubert TA, Larsen JP, Alves G, Moller SG (2019) Combinatory microRNA serum signatures as classifiers of Parkinson\u2019s disease. Parkinsonism Relat Disord. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.04.010","journal-title":"Parkinsonism Relat Disord"},{"key":"3968_CR45","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1365-2613.2001.iep195.x","volume":"82","author":"BJ Thomson","year":"2001","unstructured":"Thomson BJ (2001) Viruses and apoptosis. Int J Exp Pathol 82:65\u201376","journal-title":"Int J Exp Pathol"},{"key":"3968_CR46","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.molcel.2014.01.027","volume":"54","author":"JW Upton","year":"2014","unstructured":"Upton JW, Chan FK (2014) Staying alive: cell death in antiviral immunity. Mol Cell 54:273\u2013280. https:\/\/doi.org\/10.1016\/j.molcel.2014.01.027","journal-title":"Mol Cell"},{"key":"3968_CR47","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.nbd.2010.05.026","volume":"40","author":"SS Ambegaokar","year":"2010","unstructured":"Ambegaokar SS, Roy B, Jackson GR (2010) Neurodegenerative models in Drosophila: polyglutamine disorders, Parkinson disease, and amyotrophic lateral sclerosis. Neurobiol Dis 40:29\u201339. https:\/\/doi.org\/10.1016\/j.nbd.2010.05.026","journal-title":"Neurobiol Dis"},{"key":"3968_CR48","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/S1474-4422(17)30123-0","volume":"16","author":"RL Doty","year":"2017","unstructured":"Doty RL (2017) Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate? Lancet Neurol 16:478\u2013488. https:\/\/doi.org\/10.1016\/S1474-4422(17)30123-0","journal-title":"Lancet Neurol"},{"key":"3968_CR49","doi-asserted-by":"publisher","first-page":"17746","DOI":"10.1074\/jbc.M110.206029","volume":"286","author":"D Zhang","year":"2011","unstructured":"Zhang D, Jiang P, Xu Q, Zhang X (2011) Arginine and glutamate-rich 1 (ARGLU1) interacts with mediator subunit 1 (MED1) and is required for estrogen receptor-mediated gene transcription and breast cancer cell growth. J Biol Chem 286:17746\u201317754. https:\/\/doi.org\/10.1074\/jbc.M110.206029","journal-title":"J Biol Chem"},{"key":"3968_CR50","doi-asserted-by":"publisher","first-page":"2856","DOI":"10.1093\/nar\/gkz010","volume":"47","author":"L Magomedova","year":"2019","unstructured":"Magomedova L, Tiefenbach J, Zilberman E, Le Billan F, Voisin V, Saikali M, Boivin V, Robitaille M, Gueroussov S, Irimia M, Ray D, Patel R, Xu C, Jeyasuria P, Bader GD, Hughes TR, Morris QD, Scott MS, Krause H, Angers S, Blencowe BJ, Cummins CL (2019) ARGLU1 is a transcriptional coactivator and splicing regulator important for stress hormone signaling and development. Nucleic Acids Res 47:2856\u20132870. https:\/\/doi.org\/10.1093\/nar\/gkz010","journal-title":"Nucleic Acids Res"}],"container-title":["Molecular and Cellular Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03968-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11010-020-03968-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11010-020-03968-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T05:18:29Z","timestamp":1612934309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11010-020-03968-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,9]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["3968"],"URL":"https:\/\/doi.org\/10.1007\/s11010-020-03968-4","relation":{},"ISSN":["0300-8177","1573-4919"],"issn-type":[{"value":"0300-8177","type":"print"},{"value":"1573-4919","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,9]]},"assertion":[{"value":"2 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All the protocols were approved by the Ethics Committee of Xingtai People\u2019s Hospital. All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"All participants in this study were informed and gave a written consent.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}